EFG Asset Management (Americas)’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.98M | Sell |
10,641
-1,116
| -9% | -$207K | 0.36% | 80 |
|
|
2025
Q1 | $2.46M | Sell |
11,757
-78
| -0.7% | -$16.3K | 0.5% | 60 |
|
|
2024
Q4 | $2.1M | Buy |
11,835
+1,640
| +16% | +$291K | 0.41% | 79 |
|
|
2024
Q3 | $2.01M | Sell |
10,195
-589
| -5% | -$116K | 0.39% | 75 |
|
|
2024
Q2 | $1.85M | Buy |
10,784
+2,783
| +35% | +$477K | 0.36% | 78 |
|
|
2024
Q1 | $1.46M | Sell |
8,001
-2,001
| -20% | -$364K | 0.44% | 67 |
|
|
2023
Q4 | $1.55M | Sell |
10,002
-31
| -0.3% | -$4.8K | 0.33% | 86 |
|
|
2023
Q3 | $1.5M | Sell |
10,033
-198
| -2% | -$29.5K | 0.36% | 82 |
|
|
2023
Q2 | $1.38M | Buy |
10,231
+2,683
| +36% | +$361K | 0.32% | 86 |
|
|
2023
Q1 | $1.2M | Buy |
7,548
+528
| +8% | +$84.1K | 0.29% | 89 |
|
|
2022
Q4 | $1.13M | Buy |
7,020
+371
| +6% | +$60K | 0.28% | 91 |
|
|
2022
Q3 | $892K | Sell |
6,649
-235
| -3% | -$31.5K | 0.23% | 96 |
|
|
2022
Q2 | $1.05M | Buy |
6,884
+1,024
| +17% | +$157K | 0.25% | 87 |
|
|
2022
Q1 | $950K | Sell |
5,860
-23
| -0.4% | -$3.73K | 0.18% | 94 |
|
|
2021
Q4 | $797K | Sell |
5,883
-774
| -12% | -$105K | 0.13% | 97 |
|
|
2021
Q3 | $718K | Buy |
6,657
+297
| +5% | +$32K | 0.13% | 102 |
|
|
2021
Q2 | $716K | Buy |
6,360
+256
| +4% | +$28.8K | 0.13% | 104 |
|
|
2021
Q1 | $661K | Buy |
+6,104
| New | +$661K | 0.14% | 106 |
|
|
2015
Q1 | – | Sell |
-220
| Closed | -$14K | – | 149 |
|
|
2014
Q4 | $14K | Buy |
+220
| New | +$14K | 0.01% | 184 |
|